Second Sight Medical Products
(NASDAQ) EYES
Second Sight Medical Products Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$260.00K
Net Income (TTM)
$36.89M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
EYES News
EYES: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Second Sight Medical Products
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
42
CEO
Adam Mendelsohn, PhD
Website
www.vivani.comHeadquarters
Sylmar, CA 91342, US
EYES Financials
Key Financial Metrics (TTM)
Gross Margin
50%
Operating Margin
163162%
Net Income Margin
155596%
Return on Equity
-5%
Return on Capital
-2%
Return on Assets
-2%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$0.00
Operating Income
$24.68M
EBITDA
$24.68M
Operating Cash Flow
$20.79M
Capital Expenditure
$556.00K
Free Cash Flow
$21.34M
Cash & ST Invst.
$18.35M
Total Debt
$19.31M
Second Sight Medical Products Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
15
N/A
Net Income
$6.53M
-112.3%
EBITDA
$6.51M
-112.7%
Quarterly Fundamentals
Net Cash
$15.66M
-127.9%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$16.91M
+11096.7%
Short Term Debt
$1.39M
+817.9%
Return on Assets
-1.62%
N/A
Return on Invested Capital
-2.33%
N/A
Free Cash Flow
$5.23M
-62.3%
Operating Cash Flow
$4.41M
-36.9%